Glyheal MV 1mg/500mg/0.2mg Tablet SR
Marketer
Docheal Pharma Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glyheal MV 1mg/500mg/0.2mg Tablet SR
Diabexe-Trio 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, assisting in the regulation of blood glucose. Diabexe-Trio 1mg/500mg/0.2mg Extended-Release Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with seemingly controlled blood sugar; premature discontinuation, without medical consultation, can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications significantly contribute to diabetes control. Hypoglycemia (low blood sugar) is a prevalent adverse effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Prompt recognition and treatment are essential. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are crucial preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual blurring, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Glyheal MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glyheal MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glyheal MV 1mg/500mg/0.2mg Extended-Release Tablets should be taken on an empty stomach.
Common Side effects of Glyheal MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glyheal MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glyheal MV 1mg/500mg/0.2mg Extended-Release Tablets should be administered on an empty stomach.
How Glyheal MV 1mg/500mg/0.2mg Tablet SR works:
Glyheal MV SR tablets (1mg/500mg/0.2mg) contain a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glyheal MV 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glyheal MV 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glyheal MV tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney impairment should likely avoid Glyheal MV 1mg/500mg/0.2mg Tablet SR; its use is considered unsafe. Medical advice is recommended. Furthermore, this medication is not advised for individuals with severe kidney disease.
LiverCAUTION
Individuals with liver impairment should use Glyheal MV 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe liver dysfunction.
What if you forget to take Glyheal MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glyheal MV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glyheal MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently